KONSUMSI TABLET FE DENGAN KEJADIAN KONSTIPASI PADA IBU HAMIL TRIMESTER II DAN III

Authors

  • Lilik Rosdewati Akademi Kebidanan Langkat

DOI:

https://doi.org/10.34012/jukep.v5i2.2864

Keywords:

Fe tablets, constipation, pregnant women

Abstract

Iron is an essential nutrient needed by every human cell. Constipation or constipation is a condition that is difficult or unable to defecate, feces (feces) the feeling of defecation is not complete, or infrequent bowel movements. Relationship between Fe tablet consumption and constipation incidence in pregnant women trimester II and trimester III at Yusniar Clinic Pangkalan Brandan in 2019. This study uses an analytical method with a cross-sectional design. The population in this study was pregnant women and the sample of this study used a saturated sampling so that a sample of 30 pregnant women could be used. The study the majority of mothers who consumed Fe tablets were 28 people (87%) and the minority did not consume Fe tablets as many as 2 people (13%). The mothers who consumed Fe tablets who experienced constipation, the majority were 27 respondents (90%,) and the mothers who consumed Fe tablets who did not experience constipation were a minority of 1 respondent (10%). The results showed that there was a relationship between the consumption of Fe tablets and the incidence of constipation, with a p-value of 0.004.  It is hoped that all pregnant women take Fe tablets together with drinking enough water, consuming fiber-rich foods, regular exercise, and adequate rest so as not to experience constipation when consuming Fe tablets and following health education conducted by local health workers and following classes for pregnant women on a regular basis.

Downloads

Published

2022-08-15

How to Cite

Rosdewati, L. (2022). KONSUMSI TABLET FE DENGAN KEJADIAN KONSTIPASI PADA IBU HAMIL TRIMESTER II DAN III . Jurnal Keperawatan Priority, 5(2), 106-112. https://doi.org/10.34012/jukep.v5i2.2864

Issue

Vol. 5 No. 2 (2022)

Section

Articles

License

Copyright (c) 2022 Lilik Rosdewati

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish their manuscripts through the Journal of Keperawatan Priority agree to the following:

  • Copyright to the manuscripts of scientific papers in this Journal is held by the author.
  • The author surrenders the rights when first publishing the manuscript of his scientific work and simultaneously the author grants permission / license by referring to the Creative Commons Attribution 4.0 International License to other parties to distribute his scientific work while still giving credit to the author and the Journal of Journal Keperawatan Priority as the first publication medium for the work.
  • Matters relating to the non-exclusivity of the distribution of the Journal that publishes the author's scientific work can be agreed separately (for example: requests to place the work in the library of an institution or publish it as a book) with the author as one of the parties to the agreement and with credit to sJournal ofJournal Keperawatan Priority as the first publication medium for the work in question.
  • Authors can and are expected to publish their work online (e.g. in a Repository or on their Organization's/Institution's website) before and during the manuscript submission process, as such efforts can increase citation exchange earlier and with a wider scope.